<DOC>
	<DOCNO>NCT01284712</DOCNO>
	<brief_summary>Natural Killer cell ( NK ) pivotal cell innate immunity , sense defective expression HLA class I molecules complementary specific cytotoxic T lymphocytes . A defect NK cell cytotoxicity describe hematopoietic malignancy acute myeloid leukemia , multiple myeloma , myelodysplastic syndroms . This defect least partially link decreased absent expression activate NK cell molecule , particularly so-called Natural Cytotoxicity Receptors ( NCRs ) NKp30 , NKp44 NKp46 . Some old publication demonstrate defective NK cytotoxicity myeloproliferative syndroms ( chronic myeloid leukemia , primary thrombocytosis , polycythemia vera ) . The investigator particularly focus attention polycythemia vera ( Vaquez 's disease ) , myeloproliferative disease characterize recently describet mutation V617F JAK2 tyrosine kinase . The investigator precise mechanisms lead cytotoxicity defect , investigator also evaluate implication V617F mutation NK physiology , study interaction NK cell hematopoietic progenitor .</brief_summary>
	<brief_title>Natural Killer Cells Polycythemia Vera ( Vaquez 's Disease )</brief_title>
	<detailed_description />
	<mesh_term>Polycythemia</mesh_term>
	<mesh_term>Polycythemia Vera</mesh_term>
	<criteria>Polycythemia vera Treatment therapeutic bleeding No cytotoxic treatment previous six month No Polycythemia vera No treatment therapeutic bleeding Cytotoxic treatment previous six month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>treatment bleeding</keyword>
</DOC>